IMMUNOCORE HOLDINGS PLC 2023-2024 Proxy Voting Records

Description as filed by funds: To re-appoint as a director Professor Sir John Bell, who retires in accordance with the articles of association.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 2 : To re-appoint as a director of the Company Professor Sir John Bell.”): 30,134,392 for, 4,121,144 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 46 asset managers below reported 9,971,041 for, 874,171 against, 2,525 abstained.

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

The 44 asset managers below reported 10,834,869 for, 2,525 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: That, with effect from the conclusion of the AGM, the draft articles of association produced to the AGM and, for the purpose of identification, initialed by the Chairman, be adopted as the articles of association of the Company in substitution for, and to the exclusion of, the Company's existing articles of association.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Special Resolution Resolution 11 : That, with effect from the conclusion of the AGM, the draft articles of association produced to the AGM and, for the purpose of identification, initialed by the Chairman, be adopted as ”): 34,254,042 for, 668 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 46 asset managers below reported 10,845,212 for, 2,525 abstained.

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

Description as filed by funds: To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2023 (the "2023 U.K. Annual Report").

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 8 : To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2023 (the "2023 U.K.”): 33,905,546 for, 342,006 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 46 asset managers below reported 10,845,212 for, 2,525 abstained.

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

Description as filed by funds: To authorise the Company to make political donations/ incur political expenditure.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 10 : To authorize the Company to make political donations/incur political expenditure.”): 34,199,266 for, 56,115 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 46 asset managers below reported 10,834,869 for, 10,343 against, 2,525 abstained.

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

Description as filed by funds: To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 3 : To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.”): 33,617,866 for, 636,901 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 46 managers: 10,831,215 for, 13,997 against, 2,525 abstained. Showing the 25 largest; see all in the interactive database.

No total is shown for the institutional-manager reports: their sum exceeds the total votes cast at the meeting. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 4 : To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers.”): 34,255,074 for, 2,057 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of IMMUNOCORE HOLDINGS PLC’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote on Say on Pay Frequency” (3 managers, 72,433 1 year).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 46 managers: 1,586 for, 2,525 abstained, 10,843,626 1 year. Showing the 25 largest; see all in the interactive database.

No total is shown for the institutional-manager reports: their sum exceeds the total votes cast at the meeting. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To approve the directors' remuneration report for the year ended December 31, 2023, which is set forth as Annex A to the proxy statement and on pages 20 to 47 (inclusive) of the 2023 U.K. Annual Report.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 9 : To approve the directors' remuneration report for the year ended December 31, 2023, which is set forth as Annex A to the Proxy Statement and on pages 20 to 47 (inclusive) of the 2023 U.K. Annual Report.”): 33,719,838 for, 535,752 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 46 managers: 10,831,215 for, 13,997 against, 2,525 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 34 managers: 1,344,011 for, 61,684 against. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To authorize the directors to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2024.

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 7 : To authorize the directors to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2024.”): 34,255,844 for, 82 against, per its Form 8-K filed May 23, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 46 asset managers below reported 10,845,212 for, 2,525 abstained.

Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.

Description as filed by funds: To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2024.

The 44 asset managers below reported 10,834,869 for, 2,525 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 44 asset managers. See all 44 in the interactive database.

Description as filed by funds: To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders.

The 34 asset managers below reported 6,967,826 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 34 asset managers. See all 34 in the interactive database.

Description as filed by funds: To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders.

The 12 asset managers below reported 3,867,043 for, 2,525 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.